Cost-effectiveness of extended-release niacin/laropiprant added to a stable simvastatin dose in secondary prevention patients not at cholesterol goal in Germany

by Michailov, Galin V., Davies, Glenn M., Krobot, Karl J.
Published 2011

Cost of clinical events in health economic evaluations in Germany: a systematic review

by Scheuringer, Monika, Sahakyan, Narine, Krobot, Karl J, Ulrich, Volker
Published 2012

Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry

by Egerer, Gerlinde, Reichert, Dietmar, Pletz, Mathias W, Kaskel, Peter, Krobot, Karl J, Maertens, Johan
Published 2012

Intensive care unit-related fluconazole use in Spain and Germany: patient characteristics and outcomes of a prospective multicenter longitudinal observational study

by Wissing, Heimo, Ballus, Jose, Bingold, Tobias M, Nocea, Gonzalo, Krobot, Karl J, Kaskel, Peter, Kumar, Ritesh N, Mavros, Panagiotis
Published 2013